Aspirin Underutilized for Preeclampsia Prevention

MONDAY, Jan. 31, 2022 (HealthDay News) -- Aspirin use is underused for preeclampsia prophylaxis in women with prepregnancy diabetes, obesity, or chronic hypertension or a combination of these factors, according to a research letter published in the Jan. 25 issue of the Journal of the American Medical Association.
Joel G. Ray, M.D., from St. Michael's Hospital in Toronto, and colleagues used data from the Better Outcomes Registry and Network to identify women with a hospital livebirth or stillbirth at ≥23 weeks of gestation (371,237 births; April 1, 2018, through Dec. 31, 2020) to estimate aspirin use for preeclampsia prevention in pregnant women with prepregnancy diabetes, obesity, chronic hypertension, and combinations of these factors.
The researchers found that aspirin was used by 3.2 percent of women without any of the three risk factors versus 17.2 percent of women with diabetes, 6.9 percent of women with obesity, and 27.6 percent of women with hypertension. For women with diabetes and obesity, the rate of aspirin use was 22.2 percent versus 36.6 percent in women with diabetes and hypertension, 32.3 percent in women with obesity and hypertension, and 38.8 percent in women with all three factors.
"For the 2021 U.S. Preventive Services Task Force recommendations to be more influential, more data are needed to characterize barriers for aspirin adoption among suitable women at the patient and practitioner level, and additional knowledge translation initiatives developed," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
Many Strains of a Dangerous Foodborne Bacteria Are Now Antibiotic-Resistant
WEDNESDAY, Sept. 6, 2023 (HealthDay News) -- New research on a leading cause of...
Exercise During Pregnancy Well Tolerated by Both Maternal, Fetal Measures
THURSDAY, Aug. 17, 2023 (HealthDay News) -- Both high-intensity interval...
La COVID puede afectar los cerebros de los niños hospitalizados
LUNES, 24 de enero de 2022 (HealthDay News) -- El coronavirus puede dejar a más...
Health Highlights: Aug. 2, 2022
Dietary supplements: Are you throwing money away? A new Harris/HealthDay poll...